Full Text View
Tabular View
Study Results
Related Studies
Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.
This study has been completed.
Study NCT00527488   Information provided by Ferring Pharmaceuticals

First Received on September 10, 2007.   Last Updated on January 20, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
BPH
Additional conditions recognized in this trial
Hyperplasia
Prostatic Hyperplasia
More general conditions related to this trial
Genital Diseases, Male
Pathologic Processes
Prostatic Diseases
Interventions listed in this trial
Degarelix
Sponsors listed in this trial
Ferring Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services